SEC Form D filing

Alphina Therapeutics, Inc., 2026-03-16

An SEC Form D private-offering notice from New Haven, CT, a $10,000,000 filer-stated offering target in Biotech. Filed 2026-03-16. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Alphina Therapeutics, Inc. site↗ Verified via SEC Form D

Precision oncology biotech developing antibody drug conjugates with NAMPT inhibitor payloads to disrupt cancer cell energy metabolism.

Filed 2026-03-16Filed to raise $10,000,000First money in 2026-02-23Raised so far $153,715HQ (as filed) New Haven, CTSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified alphinatx.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source